Abstract | PURPOSE OF THE REVIEW: RECENT FINDINGS:
|
Authors | Hiroko Kadota, Takahisa Gono, Yuichiro Shirai, Yuka Okazaki, Mitsuhiro Takeno, Masataka Kuwana |
Journal | Current rheumatology reports
(Curr Rheumatol Rep)
Vol. 21
Issue 4
Pg. 10
(02 21 2019)
ISSN: 1534-6307 [Electronic] United States |
PMID | 30790071
(Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't, Review)
|
Chemical References |
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents, Immunological
- Ipilimumab
- Nivolumab
- pembrolizumab
|
Topics |
- Aged, 80 and over
- Antibodies, Monoclonal, Humanized
(adverse effects)
- Antineoplastic Agents, Immunological
(adverse effects)
- Dermatomyositis
(chemically induced)
- Female
- Humans
- Idiopathic Interstitial Pneumonias
(complications)
- Ipilimumab
(adverse effects)
- Lymph Nodes
(pathology)
- Melanoma
(drug therapy, secondary)
- Myocarditis
(chemically induced)
- Myositis
(chemically induced)
- Nivolumab
(adverse effects)
- Nose Neoplasms
(drug therapy, secondary)
- Respiratory Paralysis
(chemically induced)
- Skin Neoplasms
(pathology)
|